Preferred Label : D-bifunctional protein deficiency;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Dbp deficiency; Peroxisomal bifunctional enzyme deficiency; 17-beta-hydroxysteroid dehydrogenase iv deficiency; Pbfe deficiency;
Description : D-bifunctional protein deficiency is a disorder of peroxisomal fatty acid beta-oxidation.
See also peroxisomal acyl-CoA oxidase deficiency (264470), caused by mutation in the
ACOX1 gene (609751) on chromosome 17q25. The clinical manifestations of these 2 deficiencies
are similar to those of disorders of peroxisomal assembly, including X-linked adrenoleukodystrophy
(ALD; 300100), Zellweger cerebrohepatorenal syndrome (see 214100) and neonatal adrenoleukodystrophy
(NALD; see 601539) (Watkins et al., 1995). Mutation in the HSD17B4 gene has also been
found to cause Perrault syndrome (233400), which is characterized by sensorineural
deafness in both males and females and ovarian dysgenesis in females. Pierce et al.
(2010) noted that Perrault syndrome and DBP deficiency overlap clinically and suggested
that DBP deficiency may be underdiagnosed.;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutations in the 17-beta-hydroxysteroid dehydrogenase IV gene (HSD17B4,
601860.0001);
Laboratory abnormalities : Increased plasma levels of very long-chain fatty acids (VLCFA); Increased plasma levels of bile acid intermediates; Decreased peroxisomal fatty acid beta-oxidation; Decreased or absent D-bifunctional protein activity and protein; Normal serum plasmalogen;